Stay updated on Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Sign up to get notified when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.

Latest updates to the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page
- Check5 days agoChange DetectedAdded Prostate cancer and related topics (MedlinePlus Genetics), and Locations (Oregon). Removed HHS Vulnerability Disclosure and Oregon Locations; Revision updated to v3.3.3.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedPublications are now described as automatically filled from PubMed with a revision tag of v3.3.2; the previous description referred to PubMed-listed publications with revision v3.2.0.SummaryDifference0.1%

- Check41 days agoChange DetectedThe administrative notice about government funding and NIH operating status has been removed from the page.SummaryDifference0.4%

- Check55 days agoChange DetectedRelated topics including Prostate cancer and MedlinePlus Genetics were removed from the page.SummaryDifference0.6%

- Check62 days agoChange DetectedAdded related topics: Prostate cancer and MedlinePlus Genetics. These changes enhance topic tagging and navigation for this prostate cancer study.SummaryDifference0.2%

- Check84 days agoChange DetectedVersion bump to v3.2.0 with a government funding lapse notice; previous v3.1.0 reference removed.SummaryDifference4%

Stay in the know with updates to Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.